What is Aquablation and how does it treat benign prostatic hyperplasia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is Aquablation?

Aquablation is an image-guided robotic waterjet ablation therapy (AquaBeam system) that uses a high-velocity waterjet combined with real-time ultrasound imaging to precisely remove prostate tissue in men with benign prostatic hyperplasia (BPH). 1

How It Works

The procedure employs robotically controlled, heat-free resection that allows for targeted removal of enlarged prostate tissue while preserving surrounding structures, particularly the sphincter mechanism 2, 3. The key technical elements include:

  • Real-time ultrasound guidance for precise tissue mapping
  • High-velocity waterjet for tissue ablation (no thermal energy)
  • Robotic assistance for controlled, reproducible tissue removal
  • Post-procedure gentle bladder-neck cautery for hemostasis 4

Clinical Indications and Eligibility

Aquablation is appropriate for prostates between 30-80 mL according to current guidelines 5, though real-world data demonstrates consistent use across a much broader range of prostate sizes, including very large glands up to 1189 mL 6. The 2023 European Association of Urology guidelines classify it as an alternative ablative technique for patients with lower urinary tract symptoms (LUTS) and prostate volumes in the 30-80 mL range 1.

Efficacy Compared to Standard Treatments

Functional Outcomes

Aquablation provides noninferior functional outcomes compared to TURP (transurethral resection of the prostate) during mid-term follow-up 1. Recent prospective data shows Aquablation achieves the greatest IPSS improvement (18.9 points) compared to TURP (13.8 points) and HoLEP (14.7 points) 7.

Sexual Function Preservation

The most significant advantage of Aquablation is superior preservation of ejaculatory function 1:

  • Ejaculatory dysfunction rate: 10% with Aquablation vs. 36% with TURP 1
  • 82.8% ejaculatory function preservation compared to 36% with TURP and 18% with HoLEP 7
  • Erectile function is well-preserved (comparable to baseline) 2, 7

Safety Profile and Complications

Bleeding Concerns

Bleeding is the principal perioperative concern with Aquablation, though life-threatening events are rare 2:

  • Transfusion required in 1-8% of cases, more frequently in larger prostates 2
  • Overall rate of transfusion or return to OR for bleeding control: 0.2% in real-world data of 70,270 procedures 6
  • Significant hemoglobin drop (2.06 g/dL) reported, but transfusion need remains low 1
  • Initial hemostasis concerns have been successfully addressed with gentle bladder-neck cautery 4

Overall Complication Profile

Most complications are minor (Clavien-Dindo grade 1-2) 2:

  • Fewer overall complications than TURP (26% vs 42%) 1
  • Severe complications (grade ≥3) are uncommon, usually related to bleeding or urinary retention 2
  • Long-term sequelae (strictures, bladder neck contracture) are rare 2
  • Complication rates decline significantly after the first 30 cases, indicating a manageable learning curve 7

Retreatment Rates

Retreatment rates are slightly higher with Aquablation compared to TURP 1:

  • Aquablation: 4.3% retreatment rate
  • TURP: 1.5% retreatment rate

However, when compared to simple prostatectomy for larger prostates (>80 mL), Aquablation shows higher retreatment rates and greater reliance on postoperative alpha-blockers 8.

Practical Considerations

Advantages

  • Shorter hospital stay and catheterization time compared to traditional surgery
  • Efficient procedure with reproducible results
  • Effective across all prostate sizes in real-world practice 6
  • Superior sexual function preservation makes it ideal for sexually active men 1, 2

Limitations

  • Requires specialized equipment and training
  • Learning curve exists, though shorter than HoLEP 7
  • Slightly higher retreatment rates than TURP
  • Bleeding management requires attention to technique

Current Guideline Status

The 2020 AUA guidelines include Aquablation with updated supporting text 5, while the 2023 EAU guidelines classify it as an alternative ablative technique but note ongoing concerns about optimal hemostasis methods 1. The procedure is increasingly recognized as a valid alternative to standard resection techniques with excellent long-term functional outcomes 4.

Related Questions

Is aquablation (American Urological Association (AUA)) a recommended treatment option for benign prostatic hyperplasia (BPH)?
How should an adult male be managed during the first five days after Aquablation, regarding catheter removal, pain control, antibiotics, hydration, activity restrictions, and warning signs?
Should an adult male undergoing prostate aquablation discontinue cannabidiol (CBD) oil before surgery to avoid increased bleeding risk?
Should I be concerned about hematuria with small blood clots a day after aquablation?
I am 6 weeks post‑aquablation and recently had clot evacuation with transurethral resection of prostate and fulguration of bleeders; what postoperative care should I follow and what warning signs indicate I need urgent medical attention?
What does a fasting blood glucose of 126 mg/dL indicate and how should it be managed?
What is the appropriate management for a patient with an elevated thyroid‑stimulating hormone (TSH) level of 12.3 mIU/L and dyslipidemia characterized by total cholesterol 230 mg/dL, low‑density lipoprotein (LDL) cholesterol 151 mg/dL, high‑density lipoprotein (HDL) cholesterol 33 mg/dL, and triglycerides 296 mg/dL?
What is the best treatment for porokeratosis?
What does the imaging report indicating atherosclerotic aortic disease with infra‑renal ectasia mean?
What estimated glomerular filtration rate (eGFR) thresholds are required for initiating and dosing empagliflozin (Jardiance)?
What is the appropriate evaluation and management for a female patient with elevated mean corpuscular volume (MCV), decreased mean corpuscular hemoglobin concentration (MCHC), and elevated alkaline phosphatase (ALP)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.